2023 BMW X7 xDrive40i
3.0 L • 6 • 375 hp • 4×4 • AT
5UX23EM07P9P66304
Sales history: 1
• $42,750Highlights
Condition
Not provided
Seller
Insurance • State Farm Insurance
Key included
Yes
Docs
Good
History
1 record
Drive
3.0 L • 6 • 375 hp • 4×4 • AT
Odometer
32,972 mi ≈ 53,063 km
Primary damage
Rear end
Docs
CA • Salvage
Extra
Auction
VIN
5UX23EM07P9P66304
Lot number
71960865
Copart
Sale status
Sold
Seller type
Insurance
Seller
State Farm Insurance
Location
Trenton, NJ
Description
Fuel type
Gasoline
Body color
White
Body type
SUV
Generation
G07
Trim
xDrive40i
All sales final. Always run reports before bid
Sharing our own experience
Over the years, we’ve learned all the ins and outs of car importing — so you don’t have to.
How it works
A full step-by-step guide that walks you through the entire process — from signing up to receiving your car at your doorstep. Clear & beginner-friendly.
Purchase process
Knowledge base
A structured library of content covering every major topic in car importing — including terms, rules, key concepts, and important real-world nuances.
Import encyclopedia
Watch & learn
Short, practical videos packed with tips from real experience. No fluff, no theory — just what actually helps when importing a car from the US to Poland.
Watch guides
Popular BMW models
2023 BMW X7 xDrive40i • 3.0 L • 6 cyl • 375 hp • 4×4 • Automatic • Copart Lot: 71960865 • VIN: 5UX23EM07P9P66304
Find out more about this 2023 BMW X7 xDrive40i, available at the Copart salvage car auction as lot 71960865 in Trenton, NJ. This car has Rear end main damage. It is listed with Not provided start condition code. Odometer shows 32,972 mi. This White BMW X7 SUV is equipped with Gasoline 3.0 L engine, 4×4 drivetrain, Automatic transmission. Check the vehicle history report for 5UX23EM07P9P66304 to access detailed information on accidents, ownership, and title status. Review pricing trends and uncover hidden issues before placing your bid.
We use cookies to improve your experience and analyze site usage, as outlined in our Privacy policy. By closing this message or continuing to browse, you consent to their use.
